Method for measuring IRAK4 expression quantity

The invention discloses a sMRM targeted measurement method of interleukin-1 receptor associated kinase 4 (IRAK4) and application of the sMRM targeted measurement method. According to the method, the expression quantity of IRAK4 protein is represented by detecting the content of a symbolic peptide fr...

Full description

Saved in:
Bibliographic Details
Main Authors PENG ZHANGXIAO, FANG HOUQIN, WANG ZEHAI, SHEN JIAXI, SHU LIEBO, WANG SHAN
Format Patent
LanguageChinese
English
Published 29.09.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention discloses a sMRM targeted measurement method of interleukin-1 receptor associated kinase 4 (IRAK4) and application of the sMRM targeted measurement method. According to the method, the expression quantity of IRAK4 protein is represented by detecting the content of a symbolic peptide fragment (with uniqueness) of IRAK4; two independent symbolic peptide fragment sequences of the IRAK4 are GYVNNTTVAVK and TANTLPSK. The method comprises the following steps: pretreatment of cell sample protein, sMRM method development, and sMRM detection and data analysis of the IRAK4 in a clinical cell sample. The method can be used for evaluating the degradation amount, namely the drug effect, of various forms of drugs such as PROTAC and a small-molecule inhibitor developed by taking IRAK4 as a drug target to IRAK4 protein; the content of IRAK4 protein in various types of biological samples such as cells/plasma is quantified to assist diagnosis, detection, disease course monitoring and prognosis evaluation of infla
Bibliography:Application Number: CN202211519139